P Gardet

2.8k total citations · 2 hit papers
39 papers, 2.1k citations indexed

About

P Gardet is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Surgery. According to data from OpenAlex, P Gardet has authored 39 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Oncology and 6 papers in Surgery. Recurrent topics in P Gardet's work include Thyroid Cancer Diagnosis and Treatment (26 papers), Pituitary Gland Disorders and Treatments (6 papers) and Neuroendocrine Tumor Research Advances (4 papers). P Gardet is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (26 papers), Pituitary Gland Disorders and Treatments (6 papers) and Neuroendocrine Tumor Research Advances (4 papers). P Gardet collaborates with scholars based in France and Italy. P Gardet's co-authors include C Parmentier, Martin Schlumberger, J. Lumbroso, Bernard Caillou, Florent de Vathaire, J P Travagli, Philippe Rougier, Jean‐Paul Travagli, Agnès Laplanche and E Benhamou and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer and British Journal of Cancer.

In The Last Decade

P Gardet

38 papers receiving 2.0k citations

Hit Papers

Long-term results and prognostic factors in patients with... 1985 2026 1998 2012 1985 1986 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Gardet France 18 1.7k 851 462 417 343 39 2.1k
C S Grant United States 11 1.9k 1.1× 1.3k 1.5× 374 0.8× 461 1.1× 187 0.5× 14 2.4k
J P Travagli France 20 2.7k 1.6× 1.3k 1.6× 544 1.2× 554 1.3× 548 1.6× 30 3.1k
Dietmar Simon Germany 20 959 0.6× 690 0.8× 281 0.6× 293 0.7× 84 0.2× 56 1.6k
L. Vini United Kingdom 18 909 0.5× 507 0.6× 163 0.4× 253 0.6× 152 0.4× 27 1.3k
Marco Capezzone Italy 18 1.8k 1.1× 954 1.1× 254 0.5× 180 0.4× 187 0.5× 47 2.1k
Seiji Kuma Japan 19 1.3k 0.8× 819 1.0× 162 0.4× 207 0.5× 107 0.3× 49 1.6k
James E. Oertel United States 15 646 0.4× 1.4k 1.7× 628 1.4× 1.5k 3.6× 84 0.2× 18 2.4k
Wai‐Hon Lau China 17 837 0.5× 917 1.1× 133 0.3× 608 1.5× 110 0.3× 19 1.8k
H R Harach United Kingdom 21 928 0.5× 419 0.5× 178 0.4× 281 0.7× 48 0.1× 36 1.4k
Cathérine De Micco France 19 773 0.5× 440 0.5× 224 0.5× 199 0.5× 60 0.2× 24 1.1k

Countries citing papers authored by P Gardet

Since Specialization
Citations

This map shows the geographic impact of P Gardet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Gardet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Gardet more than expected).

Fields of papers citing papers by P Gardet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Gardet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Gardet. The network helps show where P Gardet may publish in the future.

Co-authorship network of co-authors of P Gardet

This figure shows the co-authorship network connecting the top 25 collaborators of P Gardet. A scholar is included among the top collaborators of P Gardet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Gardet. P Gardet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schlumberger, Martin, Florent de Vathaire, J P Travagli, et al.. (1996). Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.. PubMed. 37(4). 598–605. 353 indexed citations
2.
Cohen, R., et al.. (1996). [Causes of death in patients with medullary cancer of the thyroid. GETC. Groupe d'Etude des Tumeurs à Calcitonine].. PubMed. 25(37). 1819–22. 5 indexed citations
3.
Rossel, Mireille, Gilbert Lenoir, Marc Billaud, et al.. (1995). Detection of a germline mutation at codon 918 of the RET proto-oncogene in French MEN 2B families. Human Genetics. 95(4). 403–6. 27 indexed citations
4.
Gicquel, Christine, Florence Tenenbaum, C Francese, et al.. (1995). Cushing’s syndrome in medullary thyroid carcinoma. Journal of Endocrinological Investigation. 18(3). 180–185. 23 indexed citations
5.
Schlumberger, Martin, P Gardet, Ann Roche, et al.. (1994). Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. British Journal of Cancer. 69(6). 1141–1144. 53 indexed citations
6.
Schlumberger, Martin, P Gardet, Florence Tenenbaum, et al.. (1994). Screening for adrenal medullary disease in patients with medullary thyroid carcinoma. Journal of Endocrinological Investigation. 17(4). 253–257. 6 indexed citations
7.
Schlumberger, Martin, Christine Gicquel, J. Lumbroso, et al.. (1992). Malignant pheochromocytoma: Clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases. Journal of Endocrinological Investigation. 15(9). 631–642. 124 indexed citations
8.
Segond, N., et al.. (1991). Study of Calcitonin and Thyroglobulin Gene Expression in Human Mixed Follicular and Medullary Thyroid Carcinoma. Thyroid. 1(3). 249–256. 30 indexed citations
9.
Schlumberger, Martin, P Fragu, P Gardet, et al.. (1991). A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patients. European Journal of Nuclear Medicine and Molecular Imaging. 18(3). 153–157. 41 indexed citations
10.
Droz, Jean‐Pierre, et al.. (1990). Chemotherapy in Metastatic Nonanaplastic Thyroid Cancer: Experience at the Institut Gustave-Roussy. Tumori Journal. 76(5). 480–483. 72 indexed citations
11.
Noël, Michèle, F. Lasmoles, Ellen Kahn, et al.. (1990). Quantification of intracellular calcitonin gene transcripts in human medullary thyroid carcinoma (MTC) by in situ hybridization. Journal of Endocrinological Investigation. 13(7). 567–573. 3 indexed citations
12.
Rosenberg‐Bourgin, Myriam, P Gardet, Martin Schlumberger, et al.. (1989). Comparison of sporadic and hereditary forms of medullary thyroid carcinoma.. PubMed. 37(3-4). 141–3. 4 indexed citations
14.
Schlumberger, Martin, J.P. Travagli, P Fragu, et al.. (1988). Follow-up of patients with differentiated thyroid carcinoma. Experience at Institut Gustave-Roussy, Villejuif. European Journal of Cancer and Clinical Oncology. 24(2). 345–350. 30 indexed citations
15.
Baulieu, Jean‐Louis, Denis Guilloteau, R. Perdrisot, et al.. (1987). Radioiodinated meta-iodobenzylguanidine uptake in medullary thyroid cancer: A French cooperative study. Cancer. 60(9). 2189–2194. 39 indexed citations
16.
Coniat, Maryvonne Le, Danièle Vecchione, Alain Bernheim, et al.. (1987). Cytogenetic studies on patients with medullary carcinoma of the thyroid. Cancer Genetics and Cytogenetics. 25(2). 303–307. 6 indexed citations
17.
Jp, Droz, et al.. (1984). Chimiothérapie des cancers médullaires de la thyroïde. Essais phase II avec adriamycine et cis-platinum administrés en monochimiothérapie.. Bulletin du Cancer. 71(3).
18.
Rougier, P, et al.. (1984). [Chemotherapy for medullary cancer of the thyroid. Phase II trials with adriamycin and cis-platinum administered as monochemotherapy].. PubMed. 71(3). 195–9. 9 indexed citations
19.
Gardet, P, P Rougier, A. Laplanche, et al.. (1984). [Medullary thyroid cancers. Prognostic factors of nonassociated sporadic forms. Therapeutic implications].. PubMed. 71(3). 188–91. 2 indexed citations
20.
Gardet, P, C Parmentier, R Gérard-Marchant, et al.. (1978). Differentiated cancers of the thyroid: course after treatment with special reference to frequency and chronology of the first relapse for 470 treated patients.. PubMed. 20(8). 831–40. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026